EE9800281A - Kondenseeritud imidasoolderivaadid multiravimiresistentsi moduleerijatena - Google Patents

Kondenseeritud imidasoolderivaadid multiravimiresistentsi moduleerijatena

Info

Publication number
EE9800281A
EE9800281A EE9800281A EE9800281A EE9800281A EE 9800281 A EE9800281 A EE 9800281A EE 9800281 A EE9800281 A EE 9800281A EE 9800281 A EE9800281 A EE 9800281A EE 9800281 A EE9800281 A EE 9800281A
Authority
EE
Estonia
Prior art keywords
modulators
multidrug resistance
imidazole derivatives
condensed imidazole
condensed
Prior art date
Application number
EE9800281A
Other languages
English (en)
Other versions
EE03773B1 (et
Inventor
Eduard Janssens Frans
Elisabeth Leenaerts Joseph
Maria Sommen Fran�ois
Louis Nestor Ghislaine Surleraux Dominique
Original Assignee
Janssen Pharmaceutica N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica N.V. filed Critical Janssen Pharmaceutica N.V.
Publication of EE9800281A publication Critical patent/EE9800281A/et
Publication of EE03773B1 publication Critical patent/EE03773B1/et

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/04—Amoebicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/14—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
EE9800281A 1996-03-19 1997-03-11 Kondenseeritud imidasoolderivaadid, nende kasutamine ravimina, neid sisaldav farmatseutiline kompositsioon, meetod selle valmistamiseks ning seda sisaldav kombineeritud preparaat EE03773B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP96200755 1996-03-19
PCT/EP1997/001264 WO1997034897A1 (en) 1996-03-19 1997-03-11 Fused imidazole derivatives as multidrug resistance modulators

Publications (2)

Publication Number Publication Date
EE9800281A true EE9800281A (et) 1999-02-15
EE03773B1 EE03773B1 (et) 2002-06-17

Family

ID=8223797

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9800281A EE03773B1 (et) 1996-03-19 1997-03-11 Kondenseeritud imidasoolderivaadid, nende kasutamine ravimina, neid sisaldav farmatseutiline kompositsioon, meetod selle valmistamiseks ning seda sisaldav kombineeritud preparaat

Country Status (30)

Country Link
US (3) US6218381B1 (et)
EP (1) EP0888352B1 (et)
JP (3) JP3630434B2 (et)
KR (2) KR100330698B1 (et)
CN (1) CN1083453C (et)
AR (1) AR006271A1 (et)
AT (1) ATE241626T1 (et)
BG (1) BG62734B1 (et)
BR (1) BR9708140A (et)
CA (1) CA2237594C (et)
CZ (1) CZ294060B6 (et)
DE (1) DE69722389T2 (et)
EA (1) EA001004B1 (et)
EE (1) EE03773B1 (et)
ES (1) ES2200159T3 (et)
HK (1) HK1015769A1 (et)
HR (1) HRP970161B1 (et)
HU (1) HU224528B1 (et)
ID (1) ID16375A (et)
IL (1) IL124572A (et)
MX (1) MX9804426A (et)
MY (1) MY118282A (et)
NO (1) NO310659B1 (et)
NZ (1) NZ330466A (et)
PL (1) PL193444B1 (et)
SK (1) SK284434B6 (et)
TR (1) TR199801191T2 (et)
TW (1) TW527186B (et)
WO (1) WO1997034897A1 (et)
ZA (1) ZA972351B (et)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999013871A2 (en) * 1997-09-18 1999-03-25 Janssen Pharmaceutica N.V. Fused imidazole derivatives for improving oral bioavailability of pharmaceutical agents
IL138767A0 (en) * 1998-04-01 2001-10-31 Rtp Pharma Inc Anticancer compositions
US6743794B2 (en) 1999-12-22 2004-06-01 Eli Lilly And Company Methods and compounds for inhibiting MRP1
US6693099B2 (en) 2000-10-17 2004-02-17 The Procter & Gamble Company Substituted piperazine compounds optionally containing a quinolyl moiety for treating multidrug resistance
WO2002100862A2 (en) 2001-06-12 2002-12-19 Janssen Pharmaceutica N.V. Novel substituted tetracyclic imidazole derivatives, processes for their preparation, pharmaceutical compositions comprising them and their use as a medicine
MXPA04004867A (es) * 2001-11-23 2004-07-30 Janssen Pharmaceutica Nv El uso de antihistaminicos para la reduccion aguda de presion intracraneal elevada.
GB0301736D0 (en) * 2003-01-24 2003-02-26 Xenova Ltd Pharmaceutical compounds
JP6400672B2 (ja) * 2013-03-25 2018-10-03 クリスタル ファーマ エセ．ア．ウ． アルカフタジンの製造方法
CN103408549B (zh) * 2013-06-14 2016-01-20 苏州汇和药业有限公司 一种阿卡他定中间体的制备方法

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2418502C3 (de) * 1974-04-11 1980-04-24 Schering Ag, 1000 Berlin Und 4619 Bergkamen Dichlorbenzyl- [2-( a -imidazolylbutyl)-phenyl] -äther und -thioäther, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
US4153719A (en) * 1977-09-06 1979-05-08 Sterling Drug Inc. Aromatic diketones
JPS56125326A (en) * 1980-03-07 1981-10-01 Asahi Kagaku Kogyo Kk Preparation of chlorinated phenoxytoluenes in high selectivity
US4567184A (en) 1982-12-01 1986-01-28 Usv Pharmaceutical Corporation Certain aryl or hetero-aryl derivatives of 1-hydroxy-pentane or 1-hydroxy-hexane which are useful for treating inflammation and allergies
US4778931A (en) 1982-12-01 1988-10-18 Usv Pharmaceutical Corporation Certain [3-(1-hydroxy hexyl-tetrahydro)naphthalenes], the corresponding naphthalenes having anti-inflammatory and anti-allergic activity
US4794188A (en) 1982-12-01 1988-12-27 Usv Pharmaceutical Corporation Certain unsymmetrical quinolinyl ethers having anti-inflammatory and anti-allergic activity
US4588722A (en) 1984-01-09 1986-05-13 Janssen Pharmaceutica N.V. N-(4-piperidinyl) bicyclic condensed 2-imidazolamine derivatives
JPS61151176A (ja) * 1984-12-24 1986-07-09 Sumitomo Chem Co Ltd ベンズイミダゾール誘導体およびそれを有効成分とする殺虫、殺ダニ剤
US4631287A (en) * 1985-04-16 1986-12-23 Usv Pharmaceutical Corp. Aryl and heteroaryl ethers as agents for the treatment of hypersensitive ailments
AU7100887A (en) * 1986-04-07 1987-10-08 Sumitomo Chemical Company, Limited Halogenated aromatic ethers and alcohol and aldehyde intermediates
JPS6475441A (en) * 1987-09-16 1989-03-22 Sumitomo Chemical Co Production of optically active ether compound
JPH01254680A (ja) * 1988-04-01 1989-10-11 Sumitomo Chem Co Ltd 複素環化合物、その製造法およびそれを有効成分とする殺菌剤
JPH089616B2 (ja) * 1990-10-10 1996-01-31 シェリング・コーポレーション 置換されたイミダゾベンズアゼピン類およびイミダゾピリドアゼピン類
IL101851A (en) 1991-06-13 1996-05-14 Janssen Pharmaceutica Nv History 01 -) 4 - Pipridinyl - and Pipridinylidene (- Imidazo] A-1,2 [Pirolo, Thiano or Purano (] 3,2 [Azpin, their preparation and pharmaceutical preparations containing them and composition
IL101850A (en) 1991-06-13 1996-01-31 Janssen Pharmaceutica Nv History 11-) 4-Pipridinyl (-Imidazo] B-1, 2 [] 3 [Benzazepine, their preparation and pharmaceutical preparations containing them
GB9122590D0 (en) * 1991-10-24 1991-12-04 Lilly Industries Ltd Pharmaceutical compounds
ES2135463T3 (es) 1992-02-06 1999-11-01 Merrell Pharma Inc Inversion de la resistencia multi-medicamento por medio de derivados de trifenil-piperidina.
RU2134269C1 (ru) 1992-12-04 1999-08-10 Жансен Фармасетика Н.В. Производные имидазо/1,2а/тиено/2,3-d/азепинов, способ их получения, промежуточные для их получения, фармацевтическая композиция и способ их получения
CA2155759A1 (en) * 1993-03-29 1994-10-13 Bernd Janssen 1-amino-3-phenoxy propane derivatives as modulators of multi-drug resistance
CN1042228C (zh) 1993-07-13 1999-02-24 詹森药业有限公司 抗过敏咪唑并吖庚因
US5486612A (en) * 1993-12-14 1996-01-23 Eli Lilly And Company N-benzyl dihydroindole LTD4 antagonists
US5596008A (en) * 1995-02-10 1997-01-21 G. D. Searle & Co. 3,4-Diaryl substituted pyridines for the treatment of inflammation
FR2731708B1 (fr) 1995-03-13 1997-04-30 Synthelabo Derives de piperidine, leur procede de preparation et leur application en therapeutique
TW382017B (en) 1995-12-27 2000-02-11 Janssen Pharmaceutica Nv 1-(1,2-disubstituted piperidinyl)-4-(fused imidazole)-piperidine derivatives

Also Published As

Publication number Publication date
AU709683B2 (en) 1999-09-02
BG62734B1 (bg) 2000-06-30
CA2237594A1 (en) 1997-09-25
PL327985A1 (en) 1999-01-04
HK1015769A1 (en) 1999-10-22
IL124572A (en) 2002-03-10
HRP970161B1 (en) 2002-06-30
MX9804426A (es) 1998-09-30
AR006271A1 (es) 1999-08-11
HUP9900415A2 (hu) 1999-05-28
NO310659B1 (no) 2001-08-06
SK284434B6 (sk) 2005-04-01
KR100330698B1 (ko) 2002-10-31
NZ330466A (en) 1999-03-29
SK66298A3 (en) 1999-06-11
HRP970161A2 (en) 1998-04-30
TR199801191T2 (xx) 1998-10-21
AU2026997A (en) 1997-10-10
NO982124D0 (no) 1998-05-11
JP3630434B2 (ja) 2005-03-16
KR100349500B1 (ko) 2002-08-21
WO1997034897A1 (en) 1997-09-25
NO982124L (no) 1998-09-18
JP2002012594A (ja) 2002-01-15
US6476018B1 (en) 2002-11-05
US6218381B1 (en) 2001-04-17
DE69722389D1 (de) 2003-07-03
IL124572A0 (en) 1998-12-06
ID16375A (id) 1997-09-25
US20030087895A1 (en) 2003-05-08
EP0888352A1 (en) 1999-01-07
CA2237594C (en) 2006-05-30
BG102459A (en) 1999-06-30
EP0888352B1 (en) 2003-05-28
JP2000505477A (ja) 2000-05-09
EE03773B1 (et) 2002-06-17
ZA972351B (en) 1998-09-18
JP4251447B2 (ja) 2009-04-08
KR20000064358A (ko) 2000-11-06
DE69722389T2 (de) 2009-09-24
HU224528B1 (hu) 2005-10-28
ATE241626T1 (de) 2003-06-15
JP4205319B2 (ja) 2009-01-07
CZ294060B6 (cs) 2004-09-15
CN1083453C (zh) 2002-04-24
CZ152998A3 (cs) 1999-02-17
EA001004B1 (ru) 2000-08-28
MY118282A (en) 2004-09-30
BR9708140A (pt) 1999-07-27
ES2200159T3 (es) 2004-03-01
PL193444B1 (pl) 2007-02-28
HUP9900415A3 (en) 2001-11-28
EA199800586A1 (ru) 1998-12-24
JP2004067701A (ja) 2004-03-04
TW527186B (en) 2003-04-11
CN1211985A (zh) 1999-03-24

Similar Documents

Publication Publication Date Title
ATE264105T1 (de) Neue substituierte imidazolverbindungen
DE69712331D1 (de) Pyrimidin-4-on derivate als pestizidesmittel
DE69706292D1 (de) Chinazoline derivate
BR9700850A (pt) Derivados de quinazolina substituídos
PT934320E (pt) Derivados de naftiridina
PT891332E (pt) Derivados de 6-fenilpiridil-2-amina
NO20001628D0 (no) Polymerderivater av kamptoteciner
ATE290001T1 (de) Neue substituierte imidazolverbindungen
ID24638A (id) Senyawa-senyawa anti aritmia bispidina
DK0819749T3 (da) Klæbemiddelsammensætning
ID18685A (id) Senyawa trisiklik tersubstitusi
ATE277917T1 (de) Alkylaminobenzothiazole und -benzoxazole derivate
EE9800281A (et) Kondenseeritud imidasoolderivaadid multiravimiresistentsi moduleerijatena
PT923594E (pt) Compostos de bromotiacumicina
DE69727217D1 (de) Verbesserte überzugszusammensetzung
PT931087E (pt) Novos derivados de piranosido
PT906279E (pt) Derivados de pirrol
ATE211884T1 (de) Halopropargyl-einschlussverbindungen
DE69709869D1 (de) BENZO[g]CHINOLIN DERIVATE
BR9706980A (pt) Derivados de isooxacefem
BR9708310A (pt) Derivados de 2-tioxotetrahidropirimidin-4-ona
DE69635901D1 (de) Polycyclische derivate
FI991343A0 (fi) Dihydropolyprenolien öljykoostumus
DE69730098D1 (de) Klebstoffzusammensetzung
BR9708484A (pt) Aplicação de arilimidazóis substituídos

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20021231

KB4A Valid patent at the end of a year

Effective date: 20031231

KB4A Valid patent at the end of a year

Effective date: 20041231

KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20091231

MM4A Lapsed by not paying the annual fees

Effective date: 20100311